يعرض 1 - 10 نتائج من 173 نتيجة بحث عن '"Langan, S. M."', وقت الاستعلام: 1.79s تنقيح النتائج
  1. 1
  2. 2
    دورية أكاديمية

    المصدر: Bosma , A L , Ascott , A , Iskandar , R , Farquhar , K , Matthewman , J , Langendam , M W , Mulick , A , Abuabara , K , Williams , H C , Spuls , P I , Langan , S M & Middelkamp-Hup , M A 2022 , ' Classifying atopic dermatitis : a systematic review of phenotypes and associated characteristics ' , Journal of the European Academy of Dermatology and Venereology , vol. 36 , no. 6 , pp. 807-819 . https://doi.org/10.1111/jdv.18008Test

  3. 3
    دورية أكاديمية

    وصف الملف: text

    العلاقة: https://eprints.soton.ac.uk/454741/1/Br_J_Dermatol_2021_Kwiatkowska_A_summary_of_the_updated_report_on_the_incidence_and_epidemiological_trends_of.pdfTest; Kwiatkowska, M, Ahmed, S, Ardern-Jones, M R, Bhatti, L A, Bleiker, T O, Gavin, A, Hussain, S, Huws, D W, Irvine, L, Langan, S M, Millington, G W M, Mitchell, H, Murphy, R, Paley, L, Proby, C M, Thomson, C S, Thomas, R, Turner, C, Vernon, S and Venables, Z C (2022) A summary of the updated report on the incidence and epidemiological trends of keratinocyte cancers in the UK 2013-2018. British Journal of Dermatology, 186 (2), 367-369. (doi:10.1111/bjd.20764 ).

  4. 4
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: https://ueaeprints.uea.ac.uk/id/eprint/82585/1/bjd.20764.pdfTest; Kwiatkowska, M., Ahmed, S., Ardern-Jones, M. R., Bhatti, L. A., Bleiker, T. O., Gavin, A., Hussain, S., Huws, D. W., Irvine, L., Langan, S. M., Millington, G. W. M., Mitchell, H., Murphy, R., Paley, L., Proby, C. M., Thomson, C. S., Thomas, R., Turner, C., Vernon, S. and Venables, Z. C. (2022) A summary of the updated report on the incidence and epidemiological trends of keratinocyte cancers in the UK 2013–2018. British Journal of Dermatology, 186 (2). pp. 367-369. ISSN 0007-0963

  5. 5
    دورية أكاديمية

    العلاقة: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/35698725Test/; Lancet Rheumatol. 2022 Jul;4(7):e490-e506. doi:10.1016/S2665-9913(22)00098-4. Epub 2022 Jun 9.; https://rde.dspace-express.com/handle/11287/622616Test; The Lancet. Rheumatology; PMC9179144 UK National Institute for Health Research (NIHR), the NIHR School of Primary Care Research, the NIHR Oxford Biomedical Research Centre, the Mohn-Westlake Foundation, NIHR Applied Research Collaboration Oxford and Thames Valley, the Wellcome Trust, the Good Thinking Foundation, Health Data Research UK (HDRUK), the Health Foundation, WHO, UK Research and Innovation (UKRI), Asthma UK, the British Lung Foundation, and the Longitudinal Health and Wellbeing strand of the National Core Studies programme; he also receives personal income from speaking and writing for lay audiences on the misuse of science and is a non-executive director of NHS Digital. CHS received departmental research funding from AbbVie, Boehringer Ingelheim, GlaxoSmithKline, Leo, Pfizer, Novartis, Regeneron, SwedishOrphan Biovitrum, and Roche, and is an investigator within consortia that have industry partners. JG has received honoraria from AbbVie, Amgen, Celgene, Chugai, Galapagos, Gilead, Janssen, Lilly, Novartis, Pfizer, Roche, Sobi, and UCB, and has research funding from Amgen, AstraZeneca, Gilead, Janssen, Medicago, Novovax, and Pfizer. MY has received honoraria from AbbVie and UCB. CWL has received honoraria from AbbVie, Bristol Myers Squibb, Celltrion, Ferring, Galapagos, Gilead, GlaxoSmithKline, Iterative Scopes, Janssen, Fresnius Kabi, Dr Falk, Vifor Pharma, Pfizer, Takeda, and Trellus Health. CHS and SML have received grants from the Horizon 2020 European Commission-funded consortium, which has industry partners involved in manufacture of treatments for immune-mediated inflammatory diseases (see the Biomap website for complete listing). EW has received payment from AstraZeneca for providing a training session, unrelated to the current manuscript. KEM has received consulting fees from Amgen. RM has received consulting fees from Amgen. LAT has received consulting fees from Bayer (payed to the institution), support for attending Medicines and Healthcare products Regulatory Agency meetings and is a member of two non-industry-funded trial advisory committees (unpaid). SN has received grants from Pfizer and honoraria for delivering educational presentations from Pfizer and Janssen. JB is funded by a studentship from GlaxoSmithKline. HIM was an occasional invited expert to the COVID-19 Vaccines Safety Surveillance Methodologies Expert Working Group, which has now come to a close. NAK has received departmental research funding from AbbVie, Biogen, Celgene, Celtrion, Galapagos, Merck Sharp & Dohme, Napp, Pfizer, Pharmacosmos, Roche, and Takeda; consulting fees from Amgen, Bristol Myers Squibb, Dr Falk, Janssen, Mylan, Pharmacosmos, Galapagos, Takeda, and Tillotts; honoraria from Allergan, Celltrion, Dr Falk, Ferring, Janssen, Pharmacosmos, Takeda, Tilllotts, and Galapagos; and support for meetings or travel from AbbVie, Dr Falk, and Janssen. All other authors declare no competing interests.

  6. 6
    دورية أكاديمية

    المصدر: the International Eczema Council Priority Research Group , Abuabara , K , Nicholls , S G , Langan , S M , Guttman , E , Reynolds , N J & Paller , A S 2021 , ' Priority research questions in atopic dermatitis : an International Eczema Council eDelphi consensus ' , British Journal of Dermatology , vol. 185 , no. 1 , pp. 203-205 . https://doi.org/10.1111/bjd.19874Test

    وصف الملف: application/pdf

  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية

    المصدر: Mulick , A R , Mansfield , K E , Silverwood , R J , Budu-Aggrey , A , Roberts , A , Custovic , A , Pearce , N , Irvine , A D , Smeeth , L , Abuabara , K & Langan , S M 2021 , ' Four childhood atopic dermatitis subtypes identified from trajectory and severity of disease and internally validated in a large UK birth cohort ' , British Journal of Dermatology , vol. 185 , no. 3 , pp. 526-536 . https://doi.org/10.1111/bjd.19885Test